Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Quality Index
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Quality Index of 1.41x as of December 2024. Operating cash flow of CN¥690.75 Million exceeds net income of CN¥488.67 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Beijing Winsunny Pharmaceutical CO.LTD service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Beijing Winsunny Pharmaceutical CO.LTD cash flow conversion.
Annual Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year earnings quality comparison for Beijing Winsunny Pharmaceutical CO.LTD.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | CN¥690.75 Million | CN¥488.67 Million | ▲ +24.3% |
| 2023 | 1.14x | CN¥555.90 Million | CN¥488.77 Million | ▼ -24.4% |
| 2022 | 1.50x | CN¥659.76 Million | CN¥438.46 Million | ▼ -9.3% |
| 2021 | 1.66x | CN¥528.02 Million | CN¥318.12 Million | ▲ +12.8% |
| 2020 | 1.47x | CN¥386.65 Million | CN¥262.71 Million | — |